Through its portfolio of complementary brands, IBN provides (1) access to our network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release solutions so to ensure maximum impact, (4) full-scale distribution to a huge social media audience, (5) a full array of corporate communications focused on the IBN Podcast Series.
BioMedWire (BMW) is a specialized communications platform, a digital hub that aggregates and distributes news and information on the latest developments in the life sciences sector. Designed to quickly update investors on important industry news, BioMedWire is committed to keeping the public abreast of the latest developments related to emerging market opportunities in the sector.
PM360 embraces diversity, gender equality, ideas, and innovation that advance bold ideas in pharmaceutical marketing. PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex and highly regulated healthcare environment.
World Pharma Today delivers news and analysis of Pharma manufacturing, developments, regulation, legislation, policy, technology and business every weekday. As Pharma continues to move to the top of the national agenda, the editors of World Pharma Today have introduced new areas of coverage and new formats and features for accessing information, including additional reporting on Pharma, and an optimized website, in addition to special issues, exclusive supplements,and other sponsorship opportunities.